Skip to content

Relationship Between Obstructive Sleep Apnea and Coronary Atherosclerosis

Intravascular Ultrasound Diagnostic Evaluation of Atherosclerosis in Singapore- Obstructive Sleep Apnea (IDEAS-OSA) Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01306526
Acronym
IDEAS-OSA
Enrollment
118
Registered
2011-03-02
Start date
2011-02-28
Completion date
2013-03-31
Last updated
2014-01-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Artery Disease, Obstructive Sleep Apnea

Keywords

Thin-cap fibroatheroma, Vulnerable plaque, Coronary artery disease, Obstructive sleep apnea, Intravascular Ultrasound

Brief summary

Obstructive sleep apnea (OSA) is a respiratory disorder of sleep characterized by recurrent episodes of complete or partial upper airway obstruction, leading to intermittent oxygen deprivation. This results in sympathetic activation and surges in blood pressure, production of vasoactive substances, as well as activation of the inflammatory and procoagulant pathways. Epidemiological evidence indicates the prevalence of OSA is higher in patients with coronary artery disease than in the general population. The investigators recently showed that 65.7% and 41.9% of the Singapore patients admitted with myocardial infarction were found to have previously undiagnosed OSA and severe OSA, respectively. In a 10-year follow-up epidemiological study, OSA was independently associated with a higher prevalence of fatal and non-fatal cardiovascular events among the otherwise healthy general population. The investigators further showed that in patients who have undergone primary percutaneous coronary intervention for acute myocardial infarction, OSA was an independent predictor of future adverse event rates. Despite the observed association between OSA and adverse cardiovascular outcomes, the underlying pathophysiological mechanisms remain unclear. In this proposal, the investigators aim to elucidate the relationship between OSA and composition of coronary atherosclerotic plaques.

Interventions

None listed

Sponsors

National University of Singapore
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Angiogrqaphically documented coronary artery disease * De novo lesion * Native coronary artery

Exclusion criteria

* known OSA * intubation and mechanical ventilation * electrical instability with a high risk of malignant ventricular arrhythmia * cardiogenic shock * previous coronary artery bypass surgery * chronic renal failure on dialysis * inability to give informed consent

Design outcomes

Primary

MeasureTime frameDescription
Total Atheroma VolumeBaselineRelationship between OSA and Total Atheroma Volume determined (IVUS) will be determined

Secondary

MeasureTime frameDescription
Thin-cap fibroatheromaBaselineRelation between OSA and prevalence of thin-cap fibroatheroma (VH-IVUS) will be determined

Countries

Singapore

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 21, 2026